Detalles de la búsqueda
1.
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease.
BMC Cancer
; 19(1): 291, 2019 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30935383
2.
Quantitative assessment of PSMA PET response to therapy in castration-sensitive prostate cancer using an automated imaging platform for disease identification and measurement.
Eur J Hybrid Imaging
; 7(1): 7, 2023 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37009941
3.
Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19: The HITCH Randomized Clinical Trial.
JAMA Netw Open
; 5(4): e227852, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35438754
4.
Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.
Trials
; 22(1): 431, 2021 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34225789
5.
The Impact of 18F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer.
Adv Radiat Oncol
; 5(6): 1364-1369, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33305100
6.
Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer.
Eur Urol
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490853
Resultados
1 -
6
de 6
1
Próxima >
>>